SIRT1 is a regulator in high glucose-induced inflammatory response in RAW264.7 cells

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Jia, Yanhui ^a   Zheng, Zhao ^a   Wang, Yunchuan ^a   Zhou, Qin ^a   Cai, Weixia ^a   Jia, Wenbin ^a   Yang, Longlong ^a   Dong, Maolong ^a   Zhu, Xiongxiang ^a   Su, Linlin ^a   Hu, Dahai ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INTERLEUKIN 1BETA; MESSENGER RNA; SIRTUIN 1; TUMOR NECROSIS FACTOR ALPHA; 6-CHLORO-2,3,4,9-TETRAHYDRO-1H-CARBAZOLE-1-CARBOXAMIDE; AUTACOID; CARBAZOLE DERIVATIVE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; GENE EXPRESSION; INFLAMMATION; INTERLEUKIN 1BETA GENE; MACROPHAGE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SEPSIS; SIRT1 GENE; TUMOR NECROSIS FACTOR ALPHA GENE; ANIMAL; CELL SURVIVAL; DOWN REGULATION; DRUG EFFECTS; GENE SILENCING; GENETICS; METABOLISM; PATHOLOGY; RAW 264.7 CELL LINE; RNA INTERFERENCE; UPREGULATION;

ANIMALS; CARBAZOLES; CELL SURVIVAL; DOWN-REGULATION; GENE KNOCKDOWN TECHNIQUES; GLUCOSE; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; MICE; RAW 264.7 CELLS; RNA INTERFERENCE; RNA, MESSENGER; SIRTUIN 1; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84961288488     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0120849     Document Type: Article

References (36)

1. Hotchkiss RS, Opal S. Immunotherapy for sepsis - a new approach against an ancient foe. N Engl J Med. 2010; 363: 87-89. doi: 10.1056/NEJMcibr1004371 PMID: 20592301
2. Yoo CH, Yeom JH, Heo JJ, Song EK, Lee SI, Han MK. Interferon beta protects against lethal endotoxic and septic shock through SIRT1 upregulation. Sci Rep. 2014; 4: 4220. doi: 10.1038/srep04220 PMID: 24573134
3. Xu KP, Li Y, Ljubimov AV, Yu FS. High glucose suppresses epidermal growth factor receptor/phosphatidylinositol 3-kinase/Akt signaling pathway and attenuates corneal epithelial wound healing. Diabetes. 2009; 58: 1077-1085. doi: 10.2337/db08-0997 PMID: 19188434
4. Mortuza R, Chen S, Feng B, Sen S, Chakrabarti S. High glucose induced alteration of SIRTs in endothelial cells causes rapid aging in a p300 and FOXO regulated pathway. PLoS One. 2013; 8: e54514. doi: 10.1371/journal.pone.0054514 PMID: 23342163
5. Luan R, Liu S, Yin T, Lau WB, Wang Q, Guo W, et al. High glucose sensitizes adult cardiomyocytes to ischaemia/reperfusion injury through nitrative thioredoxin inactivation. Cardiovasc Res. 2009; 83: 294-302. doi: 10.1093/cvr/cvp085 PMID: 19276128
6. Dong J, Jimi E, Zeiss C, Hayden MS, Ghosh S. Constitutively active NF-kappaB triggers systemic TNFalpha-dependent inflammation and localized TNFalpha-independent inflammatory disease. Genes Dev. 2010; 24: 1709-1717. doi: 10.1101/gad.1958410 PMID: 20713516
7. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 2004; 23: 2369-2380. PMID: 15152190
8. Kauppinen A, Suuronen T, Ojala J, Kaarniranta K, Salminen A. Antagonistic crosstalk between NF-kappaB and SIRT1 in the regulation of inflammation and metabolic disorders. Cell Signal. 2013; 25: 1939-1948. doi: 10.1016/j.cellsig.2013.06.007 PMID: 23770291
9. Rai E, Sharma S, Kaul S, Jain K, Matharoo K, Bhanwer AS, et al. The interactive effect of SIRT1 promoter region polymorphism on type 2 diabetes susceptibility in the North Indian population. PLoS One. 2012; 7: e48621. doi: 10.1371/journal.pone.0048621 PMID: 23133645
10. Takeda-Watanabe A, Kitada M, Kanasaki K, Koya D. SIRT1 inactivation induces inflammation through the dysregulation of autophagy in human THP-1 cells. Biochem Biophys Res Commun. 2012; 427: 191-196. doi: 10.1016/j.bbrc.2012.09.042 PMID: 22995302
11. Wang Y, Zhao X, Shi D, Chen P, Yu Y, Yang L, et al. Overexpression of SIRT1 promotes high glucose-attenuated corneal epithelial wound healing via p53 regulation of the IGFBP3/IGF-1R/AKT pathway. Invest Ophthalmol Vis Sci. 2013; 54: 3806-3814. doi: 10.1167/iovs.13-12091 PMID: 23661372
12. Winnik S, Stein S, Matter CM. SIRT1 - an anti-inflammatory pathway at the crossroads between metabolic disease and atherosclerosis. Curr Vasc Pharmacol. 2012; 10: 693-696. PMID: 23259556
13. Yang H, Zhang W, Pan H, Feldser HG, Lainez E, Miller C, et al. SIRT1 activators suppress inflammatory responses through promotion of p65 deacetylation and inhibition of NF-kappaB activity. PLoS One. 2012; 7: e46364. doi: 10.1371/journal.pone.0046364 PMID: 23029496
14. Yang Z, Kahn BB, Shi H, Xue BZ. Macrophage alpha1 AMP-activated protein kinase (alpha1AMPK) antagonizes fatty acid-induced inflammation through SIRT1. J Biol Chem. 2010; 285: 19051-19059. doi: 10.1074/jbc.M110.123620 PMID: 20421294
15. Rajendrasozhan S, Yang SR, Kinnula VL, Rahman I. SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008; 177: 861-870. doi: 10.1164/rccm.200708-1269OC PMID: 18174544
16. Purushotham A, Schug TT, Xu Q, Surapureddi S, Guo X, Li X. Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab. 2009; 9: 327-338. doi: 10.1016/j.cmet.2009.02.006 PMID: 19356714
17. Jungo F, Dayer JM, Modoux C, Hyka N, Burger D. IFN-beta inhibits the ability of T lymphocytes to induce TNF-alpha and IL-1beta production in monocytes upon direct cell-cell contact. Cytokine. 2001; 14: 272-282. PMID: 11444907
18. Zhang FX, Kirschning CJ, Mancinelli R, Xu XP, Jin Y, Faure E, et al. Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. J Biol Chem. 1999; 274: 7611-7614. PMID: 10075645
19. Chung EY, Kim BH, Lee MK, Yun YP, Lee SH, Min KR, et al. Anti-inflammatory effect of the oligomeric stilbene alpha-Viniferin and its mode of the action through inhibition of cyclooxygenase-2 and inducible nitric oxide synthase. Planta Med. 2003; 69: 710-714. PMID: 14531020
20. De Simone R, Andres RM, Aquino M, Bruno I, Guerrero MD, Terencio MC, et al. Toward the discovery of new agents able to inhibit the expression of microsomal prostaglandin E synthase-1 enzyme as promising tools in drug development. Chem Biol Drug Des. 2010; 76: 17-24. doi: 10.1111/j.1747-0285.2010.00984.x PMID: 20492447
21. Murakami A, Matsumoto K, Koshimizu K, Ohigashi H. Effects of selected food factors with chemopreventive properties on combined lipopolysaccharide- and interferon-gamma-induced IkappaB degradation in RAW264.7 macrophages. Cancer Lett. 2003; 195: 17-25. PMID: 12767507
22. Peng C, Ma J, Gao X, Tian P, Li W, Zhang L. High glucose induced oxidative stress and apoptosis in cardiac microvascular endothelial cells are regulated by FoxO3a. PLoS One. 2013; 8: e79739. doi: 10.1371/journal.pone.0079739 PMID: 24260294
23. Ma J, Chadban SJ, Zhao CY, Chen X, Kwan T, Panchapakesan U, et al. TLR4 activation promotes podocyte injury and interstitial fibrosis in diabetic nephropathy. PLoS One. 2014; 9: e97985. doi: 10.1371/journal.pone.0097985 PMID: 24842252
24. Yi CO, Jeon BT, Shin HJ, Jeong EA, Chang KC, Lee JE, et al. Resveratrol activates AMPK and suppresses LPS-induced NF-kappaB-dependent COX-2 activation in RAW 264.7 macrophage cells. Anat Cell Biol. 2011; 44: 194-203. doi: 10.5115/acb.2011.44.3.194 PMID: 22025971
25. Centeno-Baez C, Dallaire P, Marette A. Resveratrol inhibition of inducible nitric oxide synthase in skeletal muscle involves AMPK but not SIRT1. Am J Physiol Endocrinol Metab. 2011; 301: E922-930. doi: 10.1152/ajpendo.00530.2010 PMID: 21810931
26. Shen Z, Ajmo JM, Rogers CQ, Liang X, Le L, Murr MM, et al. Role of SIRT1 in regulation of LPS- or two ethanol metabolites-induced TNF-alpha production in cultured macrophage cell lines. Am J Physiol Gastrointest Liver Physiol. 2009; 296: G1047-1053. doi: 10.1152/ajpgi.00016.2009 PMID: 19299582
27. Vachharajani VT, Liu T, Brown CM, Wang X, Buechler NL, Wells JD, et al. SIRT1 inhibition during the hypoinflammatory phenotype of sepsis enhances immunity and improves outcome. J Leukoc Biol. 2014.
28. Ichikawa T, Hayashi R, Suzuki K, Imanishi S, Kambara K, Okazawa S, et al. Sirtuin 1 activator SRT1720 suppresses inflammation in an ovalbumin-induced mouse model of asthma. Respirology. 2013; 18: 332-339. doi: 10.1111/j.1440-1843.2012.02284.x PMID: 23062010
29. Vachharajani VT, Liu T, Brown CM, Wang X, Buechler NL, Wells JD, et al. SIRT1 inhibition during the hypoinflammatory phenotype of sepsis enhances immunity and improves outcome. J Leukoc Biol. 2014; 96: 785-796. doi: 10.1189/jlb.3MA0114-034RR PMID: 25001863
30. Liu TF, Yoza BK, El Gazzar M, Vachharajani VT, McCall CE. NAD+-dependent SIRT1 deacetylase participates in epigenetic reprogramming during endotoxin tolerance. J Biol Chem. 2011; 286: 9856-9864. doi: 10.1074/jbc.M110.196790 PMID: 21245135
31. Yang H, Lee SM, Gao B, Zhang J, Fang D. Histone deacetylase sirtuin 1 deacetylates IRF1 protein and programs dendritic cells to control Th17 protein differentiation during autoimmune inflammation. J Biol Chem. 2013; 288: 37256-37266. doi: 10.1074/jbc.M113.527531 PMID: 24214980
32. Yoshizaki T, Schenk S, Imamura T, Babendure JL, Sonoda N, Bae EJ, et al. SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity. Am J Physiol Endocrinol Metab. 2010; 298: E419-428. doi: 10.1152/ajpendo.00417.2009 PMID: 19996381
33. Yoshizaki T, Milne JC, Imamura T, Schenk S, Sonoda N, Babendure JL, et al. SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes. Mol Cell Biol. 2009; 29: 1363-1374. doi: 10.1128/MCB.00705-08 PMID: 19103747
34. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature. 2005; 434: 113-118. PMID: 15744310
35. Liu TF, Vachharajani VT, Yoza BK, McCall CE. NAD+-dependent sirtuin 1 and 6 proteins coordinate a switch from glucose to fatty acid oxidation during the acute inflammatory response. J Biol Chem. 2012; 287: 25758-25769. doi: 10.1074/jbc.M112.362343 PMID: 22700961
36. Cohen J. The immunopathogenesis of sepsis. Nature. 2002; 420: 885-891. PMID: 12490963